BC

Boxer Capital Portfolio holdings

AUM $2.04B
This Quarter Return
+5.57%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$1.88B
AUM Growth
+$1.88B
Cap. Flow
-$96.7M
Cap. Flow %
-5.15%
Top 10 Hldgs %
47.5%
Holding
84
New
5
Increased
6
Reduced
10
Closed
11

Top Buys

1
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
$52.3M
2
XBI icon
SPDR S&P Biotech ETF
XBI
$36.5M
3
IMVT icon
Immunovant
IMVT
$28.8M
4
PRTA icon
Prothena Corp
PRTA
$15.7M
5
ABOS icon
Acumen Pharmaceuticals
ABOS
$9.16M

Top Sells

1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$146M
2
ETNB icon
89bio
ETNB
$39.8M
3
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$32.5M
4
CABA icon
Cabaletta Bio
CABA
$6.97M
5
IRON icon
Disc Medicine
IRON
$5.77M

Sector Composition

1 Healthcare 98.05%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
MRTX
1
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$139M 7.42% 3,201,440 +1,201,440 +60% +$52.3M
RVMD icon
2
Revolution Medicines
RVMD
$7.1B
$130M 6.9% 4,684,264 – –
ONC
3
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$89.9M 4.79% 500,000 – –
TYRA icon
4
Tyra Biosciences
TYRA
$675M
$88.8M 4.73% 6,448,359 – –
AKRO icon
5
Akero Therapeutics
AKRO
$3.74B
$84.8M 4.51% 1,676,733 – –
TNGX icon
6
Tango Therapeutics
TNGX
$747M
$80.2M 4.27% 7,123,642 – –
SWTX
7
DELISTED
SpringWorks Therapeutics
SWTX
$79.1M 4.21% 3,421,541 – –
SRPT icon
8
Sarepta Therapeutics
SRPT
$1.78B
$72.7M 3.87% 600,000 – –
APLS icon
9
Apellis Pharmaceuticals
APLS
$3.48B
$65.7M 3.5% 1,726,000 +150,000 +10% +$5.71M
CYTK icon
10
Cytokinetics
CYTK
$4.23B
$61.9M 3.29% 2,100,000 – –
IDYA icon
11
IDEAYA Biosciences
IDYA
$2.15B
$59.4M 3.16% 2,202,812 – –
NUVL icon
12
Nuvalent
NUVL
$5.52B
$55.6M 2.96% 1,210,192 – –
IMGN
13
DELISTED
Immunogen Inc
IMGN
$47M 2.5% 2,961,000 – –
MRUS icon
14
Merus
MRUS
$4.98B
$44.8M 2.39% 1,900,000 – –
KRTX
15
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$42.3M 2.25% 250,000 – –
ARGX icon
16
argenx
ARGX
$43.6B
$41.8M 2.22% 85,000 +10,000 +13% +$4.92M
LEGN icon
17
Legend Biotech
LEGN
$6.41B
$40.3M 2.15% 600,000 – –
AMLX icon
18
Amylyx Pharmaceuticals
AMLX
$836M
$38.2M 2.03% 2,084,000 – –
XBI icon
19
SPDR S&P Biotech ETF
XBI
$5.07B
$36.5M 1.94% +500,000 New +$36.5M
PRTA icon
20
Prothena Corp
PRTA
$441M
$30.2M 1.61% 625,000 +325,000 +108% +$15.7M
RCKT icon
21
Rocket Pharmaceuticals
RCKT
$354M
$30M 1.6% 1,466,051 – –
VTYX icon
22
Ventyx Biosciences
VTYX
$171M
$29.5M 1.57% 850,000 – –
IMVT icon
23
Immunovant
IMVT
$2.56B
$28.8M 1.53% +750,000 New +$28.8M
RCUS icon
24
Arcus Biosciences
RCUS
$1.13B
$28.8M 1.53% 1,602,200 – –
FOLD icon
25
Amicus Therapeutics
FOLD
$2.34B
$28.3M 1.51% 2,325,000 – –
1
2 3 4